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ABSTRACT
Objectives: In various liver disease models, including those for alcoholic liver diseases, curcumin, a polyphenolic compound derived from 
Curcuma longa, is known to have an hepatoprotective effect. However, the mechanism of action underlying its effects on alcohol-induced hepatic 
fibrosis remains unknown. We aimed to investigate the mechanisms of action underlying the effects of curcumin, mainly involving the transforming 
growth factor (TGF)-β/Smad pathway.
Methods: Hepatic stellate cells (HSCs), LX2, were incubated with 50 mM ethanol with or without curcumin (1 and 10 μM). Viable HSCs were counted 
using a LUNATM automated cell counter, whereas the expressions of TGF-β, Smad3, tissue inhibitor of metalloproteinases-1 (TIMP-1), and type 1 
collagen mRNA were measured using quantitative reverse transcriptase polymerase chain reactions.
Results: Curcumin significantly suppressed ethanol-induced HSCs proliferation. The antiproliferative effect of curcumin appeared to be dose 
dependent. In addition, the mRNA expressions of TGF-β, Smad3, TIMP-1, and type 1 collagen decreased in the cells treated with curcumin.
Conclusion: Curcumin seems to attenuate ethanol-induced HSCs proliferation through the suppression of TGF-β and appears to reduce the production 
of extracellular matrix as shown by the decreased expression of type 1 collagen.
Keywords: Curcumin, Transforming growth factor-β, Smad, Tissue inhibitor of metalloproteinases-1, Type 1 collagen.
INTRODUCTION
Heavy alcohol consumption is a causal factor of multiorgan dysfunction, 
including alcoholic liver disease (ALD) [1]. The clinical manifestations 
of ALD may vary depending on the disease stage, which can range 
from steatosis (fatty liver) to alcoholic hepatitis (fatty liver with 
inflammation). The condition can continue to progress to liver fibrosis, 
cirrhosis, and hepatocellular carcinoma [2].
Liver fibrosis is an excessive accumulation of extracellular matrix 
(ECM) as a response to liver injuries. Hepatic stellate cells (HSCs) are 
known to play an important role in the development of liver fibrosis. 
HSCs remain inactive in the normal liver as retinoid storage cells and 
are activated during the processes leading to liver fibrosis. Many in vitro 
and in vivo studies have confirmed that chronic alcoholism induces HSC 
activation [3-5]. Activation of HSCs is characterized by increased cell 
proliferation, enhanced matrix production, and expression of a number 
of proliferative and profibrogenic cytokines and their receptors [5].
Transforming growth factor (TGF)-β is an important profibrogenic 
cytokine that plays a key role in HSC activation and proliferation. TGF-β 
inhibits ECM degradation by suppressing the matrix metalloproteinases 
(MMPs) and promoting its natural inhibitor, the tissue inhibitor of 
metalloproteinases (TIMPs) [6-8]. The most recognized pathway in 
myofibroblast formation and matrix production is the TGF-β/Smad 
pathway [7]. TIMP-1 is expressed by HSCs as a response to hepatic 
inflammation. The majority of these markers are involved in the TGF-β/
Smad pathway through phosphorylation of Smad 2/3 and affect the 
transcription level in nucleus [9-11].
Curcumin is the major active substance of the plant Curcuma longa. 
Curcumin is a polyphenol, and it is well known for its anti-inflammatory 
activity in hepatocytes. Many studies show that curcumin exerts a 
hepatoprotective effect in various liver disease models, including 
ALD [12]. However, the underlying mechanism by which curcumin 
exerts its protective effects on alcohol-induced hepatic fibrosis remains 
unknown. In this study, we aimed to investigate the mechanism of 




Human immortalized HSCs (LX2) were obtained commercially from 
Merck Millipore (USA). Curcumin was purchased from Plamed, China. 
Absolute alcohol was purchased from Merck, USA. Dimethyl sulfoxide 
was purchased from Vivantis (Malaysia). Dulbecco’s Modified Eagle’s 
Medium (DMEM)-high glucose, fetal bovine serum (FBS), penicillin/
streptomycin, and amphotericin B (Fungizone®) were purchased from 
Biowest (USA). MTS Assay Kit was purchased from Promega (USA). 
High Pure RNA Isolation Kit, Transcriptor First Strand cDNA Synthesis 
Kit, and FastStart DNA Master SYBR Green I kit were obtained from 
Roche (USA).
LX2 culture
Human HSCs, LX2, were cultured and maintained at 37°C in a 5% CO2 
air atmosphere in DMEM-high glucose supplemented with 10% heat-
inactivated FBS, 10 U/L penicillin, 100 μg/mL streptomycin, and 2.5 μg/
mL amphotericin B. Curcumin were given to the cells with or without 
alcohol.
Cells were seeded at 5000 cells per well in a 12-well plate and 
incubated for 72 h. Curcumin 1 and 10 μM were added to the cells with 
or without prior treatment with alcohol 50 μM for 24 h. The dose of 
curcumin was selected on the basis of our previous study by Lin et al. 
[13] in the cultured HSC from rats. After 24 h of curcumin treatment, 
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cells were harvested and counted for cell viability using Trypan Blue 
Exclusion Method. Harvested cells were isolated for total RNA and 
further synthesized to cDNA for real-time polymerase chain reaction 
(PCR) analysis. Experiments were done 3 times in duplicate.
Quantitative reverse transcription PCR analysis
Total cellular RNA was extracted from 1,000,000 cells following 
trypsinization, using High Pure RNA Isolation Kit (Roche, USA). 
Then, 1 µg of RNA was converted to cDNA using a Transcriptor First 
Strand cDNA Synthesis Kit (Roche, USA). A quantitative real-time 
PCR was performed on 100 ng cDNA using FastStart DNA Master 
SYBR Green 1 kit (Roche, USA) according to the manufacturer’s 
protocol with β-actin as housekeeping gene. Primer sequences for 
TGF-β-Fwd: 5’-TGAACCGGCCTTTCCTGCTTCTACATG-3’; TGF-β-Rev: 
5’-GCGGAAGTCAATGTACAGCTGCCGC-3’; Smad3-Fwd: GTCTGCAAGAT 
CCCACCAG, Smad3-Rev: AGCCCTGGTTGACCGACT; collagen 1A1 
(Col1A1)-Fwd: AGGTCCCCCTGGAAAGAA, Col1A1-Rev: AATCCTCG 
AGCACCCTGA; TIMP1-Fwd: GGCTGTGAGGAATGCACA; TIMP1-Rev: TGG 
AAGCCCTTTTCAGAGC; β-actin-Fwd: 5’GCTGGAAGGTGGACAGCGA-3’; 
β-actin-Rev: 5’-GGCATCGTGATGGACTCCG-3’.
Statistical analysis
Results were presented as mean±standard deviation. Statistical 
analysis was performed using one-way analysis of variance. Statistical 
significance was determined at the level of p<0.05.
RESULTS
Our results showed that alcohol increased the cell viability by 
approximately two-fold that of the control. Treatment with curcumin 
appeared to normalize cell viability; however, a higher dose of 
curcumin leads to a significant decrease of cell viability compared with 
the control (Fig. 1).
The increased cell viability was in accordance with the increase in TGF-β 
mRNA and Smad3 mRNA expressions. With curcumin treatment, the 
increases in TGF-β mRNA and Smad3 mRNA expressions approached 
normal values (Figs 2 and 3).
Treatment with alcohol resulted in an increase in the expression of 
Col1A1. Curcumin at a low dose did not reverse the increase in Col1A1 
expression; however, a high dose of curcumin increased the expression 
of Col1A1 even more markedly than alcohol alone (Fig. 4).
The mRNA expression of TIMP increased with alcohol. Curcumin 
considerably decreased the mRNA expressions of TIMP-1, even to 
values below the normal (Fig. 5). However, no dose-dependent effect 
was observed.
DISCUSSION
It has been demonstrated in previous studies that curcumin had 
antifibrotic activity in many liver diseases, including ALD; however, 
the exact underlying mechanism remains unknown [14-17]. The 
TGF-β/Smad signaling pathway is a major pathway involved in 
fibrogenesis [7,8]; therefore, we have investigated whether curcumin 
exerts any effects on this pathway.
Many cytokines are involved in the development of fibrosis. TGF-β and 
platelet-derived growth factor (PDGF) are the two major cytokines 
involved in fibrogenesis. PDGF is a potent proliferative cytokine, 
and TGF-β is a potent fibrogenic factor that greatly influences the 
cellular processes such as differentiation, proliferation, apoptosis, and 
migration [7,18-20]. After alcohol consumption, the primary metabolite 
of ethanol and acetaldehyde induces hepatocyte destruction and the 
release of profibrogenic cytokines. Profibrogenic cytokines stimulate HSC 
activation through paracrine signaling. After HSC activation, these 
cells produce TGF-β and continued fibrogenesis through paracrine 
signaling [21,22]. Alcohol could directly activate HSC through the 
toll-like receptor-4 (TLR4) signaling pathway and thus increase 
profibrogenic cytokine production [17].
Our study showed that there was a significant increase in proliferation of 
HSCs and the level of TGF-β mRNA expression under direct stimulation 
with alcohol. This result supports the mechanisms underlying the 
alcohol toxicity proposed in a previous study, in which the TLR4 
signaling pathway led to the production of pro-inflammatory mediators 
and profibrogenic factor including TGF-β and PDGF. In the development 
of liver fibrosis, TLR4 is also expressed on recruited macrophages, 
hepatocytes, sinusoidal endothelial cells, and HSC [17]. Consequently, 
these cells can contribute to liver inflammation through TLR4 signaling, 
by releasing proinflammatory cytokines and chemokines. As a result, 
HSCs can also contribute to the development of alcoholic fibrosis by 
enhancing TGF-β signaling [17]. This mechanism explains the results 
of our study, in which the direct stimulation of HSCs with alcohol can 
Fig. 1: Number of viable cells after treatment with vehicle only, 
alcohol, alcohol+curcumin 1 μM, and alcohol+curcumin 10 μM. 
Results are presented as mean±standard deviation, *p<0.05 
versus vehicle, #p<0.05 versus alcohol. Veh: Vehicle; Alc: Alcohol; 
Alc+Cur1: Alcohol+curcumin 1 μM; Alc+Cur10: Alcohol+curcumin 
10 μM
Fig. 2: Transforming growth factor-β mRNA expressions after 
LX-2 treatment with vehicle only, alcohol, alcohol+curcumin 
1 μM, or alcohol+curcumin 10 μM. Results are presented as 
mean+standard deviation, *p<0.05 versus vehicle, #p<0.05 versus 
alcohol. Veh: Vehicle; Alc: Alcohol; Alc+Cur1: Alcohol+curcumin 1 
μM; Alc+Cur10: Alcohol+curcumin 10 μM
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increase the expression of TGF-β, thus stimulating HSC proliferation.
The major pathway responsible for HSC activation is TGF-β/Smad 
pathway. There are several types of Smad proteins in the Smad family 
that is involved in the TGF-β/Smad signaling pathway. Yet Smad3, a 
regulatory Smad protein, seems to be the most important Smad in 
fibrogenesis. Phosphorylated Smad2/3, in collaboration with coSmad 4, 
is transported into the nucleus and acts as a transcription factor for the 
profibrogenic marker α-SMA and Col1A1 [7,23,24]. A previous study 
showed that the activation of HSC was correlated with increasing levels of 
Smad 3 mRNA expression [17]. In our study, we confirmed that induction 
by ethanol significantly increased the expression of Smad3 mRNA and 
profibrogenic marker Col1A1 expression. Activation of HSCs releases 
TGF-β and promotes fibrogenesis by decreasing MMPs and promoting 
its natural inhibitor, TIMP [7]. In the present study, we confirmed that 
induction of ethanol significantly increased TIMP-1 expressions. Thus, 
we confirmed that, in our model, ethanol induction was successful. 
Further, HSCs were markedly activated, and all the profibrogenic 
markers of HSC activation were significantly increased. These results 
are in accordance with those of a previous study, suggesting that ethanol 
induction will result in a significant increase in Smad3, TIMP-1, and 
Col1A1 expression on LX2 cells induced by ethanol [25,26].
Our study showed that curcumin suppressed the proliferation of HSCs 
under stimulation with ethanol. Curcumin significantly decreased the 
mRNA TGF-β expression, and this effect appeared to be dose dependent. 
Our result is consistent with a previous study in which curcumin 
reduced TGF-β expressions in the livers of CCl4-treated rats. Altogether, 
these findings suggest that the downregulation of TGF-β by curcumin 
may be the key underlying mechanisms of its antifibrogenic effects [26]. 
The examination of the signal molecules in the TGF-β/Smad pathway 
showed that curcumin decreased Smad3 mRNA expression during HSC 
activation [26]. Our study confirmed that curcumin decreased Smad3 
expression. TGF-β also promotes fibrogenesis by inhibiting MMPs 
and promoting its natural inhibitor, TIMPs [27]. Our study showed 
that inhibition of TGF-β in activated HSC by curcumin was in line with 
decreasing TIMP-1 expressions. This result was in accordance with a 
previous study done by Liu et al. [26].
As described above, ethanol induction activated the HSCs through 
TLR signaling. TLR4, one receptor for lipopolysaccharide receptor, 
can trigger two different signaling pathways, in which one is a myeloid 
differentiation factor 88-dependent pathway and leads to the rapid 
activation of nuclear factor-κB (NF-κB) [26]. NF-κB is commonly 
associated with liver fibrosis, including ALD. Although NF-κB is 
not required for the activation of HSCs, an increase in the p65/p50 
heterodimer, with a concomitant decrease in the NF-κB inhibitory 
protein, IκBα, promotes the survival of activated HSCs. Overexpression 
of NF-κB in activated HSCs, however, has been shown to inhibit α1(I) 
and α2(I) collagen mRNA expression in culture-activated HSCs [26,28]. 
Many studies showed that curcumin reduces the transcription 
activation of NF-kB [29-31]. These facts suggest our result that 
curcumin treatment did not affect Col1A1 expression.
CONCLUSION
Collectively, our results suggest that the antiproliferative effects of 
curcumin played by its ability to inhibit TGF-β in alcohol-induced HSC. 
Inhibition of the TGF-β/Smad pathway by curcumin decreases Smad3 
Fig. 3: Smad3 mRNA expressions after LX-2 treatment with vehicle 
only, alcohol, alcohol+curcumin 1 μM, or alcohol+curcumin 
10 μM. Results are presented as mean+standard deviation, *: 
p<0.05 versus vehicle, #: p<0.05 versus alcohol. Veh: Vehicle; 
Alc: Alcohol; Alc+Cur1: Alcohol+curcumin 1 μM; Alc+Cur10: 
Alcohol+curcumin 10 μM
Fig. 4: Collagen 1A1 mRNA expressions after LX-2 
treatment with vehicle only, alcohol, alcohol+curcumin 
1 μM, or alcohol+curcumin 10 μM. Results are presented as 
mean±standard deviation, *p<0.05 versus vehicle, #p<0.05 versus 
alcohol. Veh: Vehicle; Alc: Alcohol; Alc+Cur1: Alcohol+curcumin 
1 μM; Alc+Cur10: Alcohol+curcumin 10 μM
Fig. 5: Tissue inhibitor of metalloproteinases-1 mRNA 
expressions after LX-2 treatment with vehicle only, alcohol, 
alcohol+curcumin 1 μM, or alcohol+curcumin 10 μM. Results are 
presented as mean±standard deviation, *p<0.05 versus vehicle, 
#p<0.05 versus alcohol. Veh: Vehicle; Alc: Alcohol; Alc+Cur1: 
Alcohol+curcumin 1 μM; Alc+Cur10: Alcohol+curcumin 10μM
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and TIMP-1 expressions. Thus, curcumin will affect matrix degradation 
during fibrogenesis. Therefore, this study suggested the possibility of 
using curcumin as a potential candidate in the treatment of ALD.
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